Express Pharma

Lallemand Health Solutions to launch innovative probiotics at CPhI Madrid

2

In addition, the company will present a new range of probiotic strains to address targeted segments of the immunity market

Lallemand Health Solutions will be presenting a new concept in probiotics formulation at the forthcoming CPhI Worldwide trade show in Madrid, from October 13-15, 2015.

Probiotic 2.0 is the synergetic association of documented probiotic bacteria and yeast (S boulardii), for overall digestive health, from oral health to gut microflora balance. In addition, the company will present a new range of probiotic strains to address targeted segments of the immunity market, as well as its full line of ready-to-market probiotic formula and strains for custom formulations in other areas such as gut health, emotional equilibrium, women’s health or oral health.

Lallemand Health Solutions has the industrial ability and know-how to develop specific probiotic formulations combining pharma grade S boulardii yeast with documented probiotic bacteria. The company offers its partners a selected range of well documented bacteria strains to be combined with S boulardii to address overall digestive health, from oral health to gut health, for a new, holistic approach to digestive health.

The interactions between probiotics and immunity are increasingly well understood. Thanks to a strong R&D programme dedicated to immunity, encompassing innovative in vitro, in vivo and clinical studies, scientists at Lallemand Health Solutions are able to draw a better picture of the pathways involved and the clear benefits of selected probiotic strains and strains combinations. On this basis, the company has developed a portfolio of probiotic strains and strains combinations to address various issues of immune health for different target population groups. They are prevention of infections or atopic disorders in children; prevention of chronic or acute infections in at-risk adults (under chronic stress, athletes) and immune modulation in seniors susceptible to lower immune response or chronic inflammation (inflammaging).

These strains can be formulated into specific solutions, associated to certain vitamins or minerals for example, in formats adapted to each target population: capsules, convenient orodispersible sticks, sachets to dissolve in drinks or food etc.

EP News BureauMumbai

Comments are closed.